SERAPIS

Welcome to the Brand page for “SERAPIS”, which is offered here for Anti-diabetic pharmaceuticals; antibacterial pharmaceuticals; cardiovascular pharmaceuticals; cells for medical or clinical use; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical anti-allergic preparations and substances; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical products for treating respiratory diseases and asthma; pharmaceuticals, anti-infectives; pharmaceuticals, lipid lowering agents;.

Its status is currently believed to be active. Its class is unavailable. “SERAPIS” is believed to be currently owned by “Rifai, Abdalla”.